486 related articles for article (PubMed ID: 17141392)
1. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
Kassa J; Karasova J
Toxicology; 2007 Jan; 229(1-2):136-44. PubMed ID: 17141392
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
Kassa J; Kunesova G
J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727
[TBL] [Abstract][Full Text] [Related]
3. The evaluation of neuroprotective efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
Kassa J; Karasova J; Vasina L
J Appl Toxicol; 2007; 27(6):621-30. PubMed ID: 17685413
[TBL] [Abstract][Full Text] [Related]
4. A comparison of neuroprotective efficacy of the oxime K203 and its fluorinated analogue (KR-22836) with obidoxime in Tabun-poisoned rats.
Kassa J; Karasova JZ; Tesarova S; Musilek K; Kuca K; Jung YS
Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):861-7. PubMed ID: 22545968
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) to counteract soman-induced neurotoxicity in rats.
Kassa J; Karasova J
Drug Chem Toxicol; 2007; 30(2):117-31. PubMed ID: 17454028
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
Kassa J; Karasova JZ; Bajgar J; Tesarova S; Kuca K; Musilek K
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):228-35. PubMed ID: 19143747
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of the neuroprotective effects of bispyridinium oximes in tabun-poisoned rats.
Kassa J; Karasova J
J Toxicol Environ Health A; 2007 Sep; 70(18):1556-67. PubMed ID: 17710615
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the ability of newly-developed bispyridinium oxime K203 and currently available oximes (trimedoxime, obidoxime, HI-6) to counteract the acute neurotoxicity of soman in rats.
Kassa J; Karasova JZ; Tesarova S; Kuca K; Musilek K
Toxicol Mech Methods; 2010 Oct; 20(8):445-51. PubMed ID: 20738156
[TBL] [Abstract][Full Text] [Related]
10. A comparison of neuroprotective efficacy of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in tabun-poisoned rats.
Kassa J; Karasova J; Vasina L; Bajgar J; Kuca K; Musilek K
Drug Chem Toxicol; 2009; 32(2):128-38. PubMed ID: 19514949
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats.
Kassa J; Misik J; Karasova JZ
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):333-8. PubMed ID: 22536919
[TBL] [Abstract][Full Text] [Related]
12. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the potency of two novel bispyridinium oximes (K456, K458) in comparison with oxime K203 and trimedoxime to counteract tabun-induced neurotoxicity in rats.
Kassa J; Misik J; Karasova JZ
Basic Clin Pharmacol Toxicol; 2013 Sep; 113(3):201-8. PubMed ID: 23647829
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of currently used antidotes in tabun-poisoned rats.
Kassa J; Krejèová G
Pharmacol Toxicol; 2003 Jun; 92(6):258-64. PubMed ID: 12787257
[TBL] [Abstract][Full Text] [Related]
15. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats.
Kassa J; Jun D; Karasova J; Bajgar J; Kuca K
Chem Biol Interact; 2008 Sep; 175(1-3):425-7. PubMed ID: 18547554
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice.
Kassa J; Humlicek V
Drug Chem Toxicol; 2008; 31(1):127-35. PubMed ID: 18161512
[TBL] [Abstract][Full Text] [Related]
17. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.
Kassa J; Karasova JZ; Pavlikova R; Misik J; Caisberger F; Bajgar J
J Appl Toxicol; 2010 Mar; 30(2):120-4. PubMed ID: 19746406
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.
Kassa J; Karasova J; Bajgar J; Kuca K; Musilek K; Kopelikova I
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1040-4. PubMed ID: 19552519
[TBL] [Abstract][Full Text] [Related]
19. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
Kassa J; Jun D; Kuca K
J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the potency of newly developed oximes (K347, K628) and currently available oximes (obidoxime, HI-6) to counteract acute neurotoxic effects of Tabun in rats.
Kassa J; Karasová JZ; Tesarová S; Musílek K; Kuca K
Acta Medica (Hradec Kralove); 2010; 53(2):85-91. PubMed ID: 20672744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
